Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 453 Issue 7197, 12 June 2008

A low tissue pH is often associated with disease - for example cancer, ischaemia and inflammation - so a technique that could image tissue pH would have considerable potential for disease diagnosis and for monitoring response to treatment. A new, non-invasive method of pH imaging has now been devised, and demonstrated by monitoring the extracellular pH in living mice. It combines magnetic resonance imaging (MRI) and the intravenous injection of carbon-13-labelled bicarbonate - made extremely sensitive to detection by the use of dynamic nuclear polarization. Bicarbonate is a natural buffer in mammalian tissues, resisting pH change via interconversion with carbon dioxide in the reaction catalysed by carbonic anhydrase. The ratio of labelled bicarbonate to carbon dioxide can be used to calculate pH from the Henderson-Hasselbalch equation. Images of mice with implanted tumours confirmed a reduced tumour pH, and suggest that clinical application of the new technique is a realistic proposition. On the cover, colur in the images represents pH. Cover graphic: Mikko Kettunen & Rebekah McLaughlin.

Editorial

  • Translational medicine is a key addition to the biomedical research enterprise. Policy-makers and research leaders now must build the infrastructure to take discoveries from the bench to application.

    Editorial

    Advertisement

  • ITER will cost more to build than previously thought. Now is the time to be honest about how much.

    Editorial
  • The use of 'dignity' as the foundation for an ethical law in Switzerland is compromising research.

    Editorial
Top of page ⤴

Research Highlights

Top of page ⤴

Journal Club

Top of page ⤴

News

Top of page ⤴

News in Brief

  • Scribbles on the margins of science.

    News in Brief
Top of page ⤴

News

Top of page ⤴

News in Brief

Top of page ⤴

Correction

Top of page ⤴

Column

  • Near-term and long-term research are vying for attention. David Goldston says that a fuller congressional debate is needed.

    • David Goldston
    Column
Top of page ⤴

News Feature

  • A chasm has opened up between biomedical researchers and the patients who need their discoveries. Declan Butler asks how the ground shifted and whether the US National Institutes of Health can bridge the gap.

    • Declan Butler
    News Feature
  • Results can be thrust from bench to bedside, but there is also much to be learned by pushing the other way. Heidi Ledford tells tales of clinical trials that have prompted a change in tack.

    • Heidi Ledford
    News Feature
  • The Ludwig Institute for Cancer Research is focused on translating research into cures. Helen Pearson investigates whether its sometimes unusual methods are producing results.

    • Helen Pearson
    News Feature
Top of page ⤴

Correspondence

Top of page ⤴

Commentary

  • If Japan is to become a front-runner in pharmaceutical development, it must not only speed up its approval of new drugs, but also enhance its own research capabilities, argue Kaori Tsuji and Kiichiro Tsutani.

    • Kaori Tsuji
    • Kiichiro Tsutani
    Commentary
  • Fuelling innovation requires a different kind of collaboration between industrial and academic researchers, argues Bill Destler.

    • Bill Destler
    Commentary
Top of page ⤴

Books & Arts

Top of page ⤴

Essay

  • Michael Barron explores how physics, psychology and fashion have influenced concert hall acoustics.

    • Michael Barron
    Essay
Top of page ⤴

News & Views

  • Protease enzymes cut other proteins into pieces, but some can be blocked by inhibitors. One such inhibitor binds to the substrate rather than the enzyme, suggesting a new tactic for drug discovery.

    • Thomas Kodadek
    News & Views
  • A long-sought but short-lived molecule has been made and characterized for the first time. This compound decays at low temperatures using an unusual trick — a mechanism known as quantum tunnelling.

    • Markku Räsänen
    News & Views
  • A monkey model of Huntington's disease created by gene transfer is only a work in progress. But as a technological feat it offers great promise for fathoming this devastating condition.

    • Stéphane Palfi
    • Bechir Jarraya
    News & Views
  • Periodic oscillations have been observed in what should be straightforward exponential decay curves of two radioactive isotopes. An entirely mysterious phenomenon, its proposed cause seems equally exotic.

    • Philip M. Walker
    News & Views
  • In a disordered medium, a quantum particle can literally stop itself in its tracks. This localization phenomenon can be observed directly using the coldest known form of matter, caught in a laser trap.

    • Daniel A. Steck
    News & Views
Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Corrigendum

Top of page ⤴

Prospects

Top of page ⤴

Movers

Top of page ⤴

Networks and Support

Top of page ⤴

Career View

Top of page ⤴

Futures

Top of page ⤴

Authors

Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links